Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs3830227 | chr10:1132749 | GTAGT/G | 1.75E-5 | 132 | 46.3 | 37.1 | 33.52 | KM Plot |
| TGCT | rs3834245 | chr5:1810191 | C/CT | 5.72E-6 | 133 | 42.27 | 43.9 | 24.73 | KM Plot |
| TGCT | rs3835138 | chr12:129278281 | TA/TAA | 1.8E-5 | 133 | 41.33 | 42.27 | 29.53 | KM Plot |
| TGCT | rs3837141 | chr7:127664117 | CTG/CTGTG | 6.48E-5 | 132 | 46.53 | 37.1 | 9.77 | KM Plot |
| TGCT | rs3840940 | chr19:37903316 | A/AT | 1.77E-13 | 133 | 45.1 | 37.53 | 17.1 | KM Plot |
| TGCT | rs385122 | chr17:39341294 | T/A | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs385380 | chr17:39367672 | C/T | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs388650 | chr17:39341646 | C/T | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs398825 | chr17:39340707 | C/T | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs404052 | chr17:39340262 | T/G | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs4052459 | chr13:78235993 | A/G | 1.1E-5 | 132 | 15.7 | 35.37 | 42.18 | KM Plot |
| TGCT | rs405495 | chr17:39339089 | T/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs4070 | chr4:47438731 | C/A | 0.000153 | 131 | 46.3 | 36.1 | 51.6 | KM Plot |
| TGCT | rs407264 | chr17:39339991 | C/T | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs4084708 | chr3:172441246 | G/A | 1.49E-5 | 134 | 24.15 | 37.3 | 45.1 | KM Plot |